These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31323964)

  • 1. Identification of Retinal Biomarkers in Alzheimer's Disease Using Optical Coherence Tomography: Recent Insights, Challenges, and Opportunities.
    Cabrera DeBuc D; Gaca-Wysocka M; Grzybowski A; Kanclerz P
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31323964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oximetry: recent insights into retinal vasopathies and glaucoma.
    Boeckaert J; Vandewalle E; Stalmans I
    Bull Soc Belge Ophtalmol; 2012; (319):75-83. PubMed ID: 22550781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglion Cell Layer Thinning in Alzheimer's Disease.
    López-de-Eguileta A; Cerveró A; Ruiz de Sabando A; Sánchez-Juan P; Casado A
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33096909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of optical coherence tomography in Alzheimer's disease.
    Cunha LP; Almeida AL; Costa-Cunha LV; Costa CF; Monteiro ML
    Int J Retina Vitreous; 2016; 2():24. PubMed ID: 27847642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
    Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
    Front Neurol; 2017; 8():701. PubMed ID: 29312125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases.
    Satue M; Obis J; Rodrigo MJ; Otin S; Fuertes MI; Vilades E; Gracia H; Ara JR; Alarcia R; Polo V; Larrosa JM; Pablo LE; Garcia-Martin E
    J Ophthalmol; 2016; 2016():8503859. PubMed ID: 27840739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.
    Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY
    J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
    J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
    Gupta S; Zivadinov R; Ramanathan M; Weinstock-Guttman B
    Expert Rev Neurother; 2016 Jul; 16(7):765-75. PubMed ID: 27138997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease.
    Garcia-Martin E; Bambo MP; Marques ML; Satue M; Otin S; Larrosa JM; Polo V; Pablo LE
    Acta Ophthalmol; 2016 Sep; 94(6):e454-9. PubMed ID: 26895692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.
    Cunha JP; Proença R; Dias-Santos A; Almeida R; Águas H; Alves M; Papoila AL; Louro C; Castanheira-Dinis A
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1827-1835. PubMed ID: 28643042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.
    Cunha JP; Moura-Coelho N; Proença RP; Dias-Santos A; Ferreira J; Louro C; Castanheira-Dinis A
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2079-2092. PubMed ID: 27377656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Structural Retinal Biomarkers to Detect Cognitive Impairment in a Primary Care Setting.
    Mozdbar S; Petersen M; Zhang F; Johnson L; Tolman A; Nyalakonda R; Gutierrez A; O'Bryant S
    J Alzheimers Dis Rep; 2022; 6(1):749-755. PubMed ID: 36721487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
    Lambe J; Murphy OC; Saidha S
    Curr Treat Options Neurol; 2018 Mar; 20(4):9. PubMed ID: 29564662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography.
    Thomson KL; Yeo JM; Waddell B; Cameron JR; Pal S
    Alzheimers Dement (Amst); 2015 Jun; 1(2):136-43. PubMed ID: 27239501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macular Thickness Measurements with Frequency Domain-OCT for Quantification of Retinal Neural Loss and its Correlation with Cognitive Impairment in Alzheimer's Disease.
    Cunha LP; Lopes LC; Costa-Cunha LV; Costa CF; Pires LA; Almeida AL; Monteiro ML
    PLoS One; 2016; 11(4):e0153830. PubMed ID: 27104962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography as a potential readout in clinical trials.
    Greenberg BM; Frohman E
    Ther Adv Neurol Disord; 2010 May; 3(3):153-60. PubMed ID: 21179607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
    Saidha S; Syc SB; Ibrahim MA; Eckstein C; Warner CV; Farrell SK; Oakley JD; Durbin MK; Meyer SA; Balcer LJ; Frohman EM; Rosenzweig JM; Newsome SD; Ratchford JN; Nguyen QD; Calabresi PA
    Brain; 2011 Feb; 134(Pt 2):518-33. PubMed ID: 21252110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retinal optical coherence tomography biomarkers and their association with cognitive functions : Clinical and artificial intelligence approaches. German version].
    Rauscher FG; Bernardes R
    Ophthalmologie; 2024 Feb; 121(2):105-115. PubMed ID: 38285070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.